ストックスクリーナーアプリを入手
1.47
8.89%
0.12
アフターアワーズ：
1.35
-0.12
-8.16%
前日終値:
$1.35
開ける：
$1.35
24時間の取引高:
391.56K
Relative Volume:
2.33
時価総額：
$17.38M
収益：
$17.32M
当期純損益:
$-17.10M
株価収益率:
-0.7448
EPS:
-1.9737
ネットキャッシュフロー:
$-15.37M
1週間 パフォーマンス:
+22.50%
1か月 パフォーマンス:
+18.55%
6か月 パフォーマンス:
-53.33%
1年 パフォーマンス:
-32.88%
1日の値動き範囲:
$1.33
$1.54
1週間の範囲:
$1.15
$1.54
52週間の値動き範囲:
$1.085
$7.95
Vivos Therapeutics Inc Stock (VVOS) Company Profile
名前
Vivos Therapeutics Inc
セクター
電話
(866)908-4867
住所
7921 SOUTHPARK PLAZA,, LITTLETON
Compare VVOS vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
VVOS
Vivos Therapeutics Inc
|
1.47 | 15.96M | 17.32M | -17.10M | -15.37M | -1.9737 |
ABT
Abbott Laboratories
|
101.56 | 175.59B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
341.24 | 132.47B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
87.10 | 113.14B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
64.61 | 94.85B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
78.20 | 45.09B | 6.07B | 1.06B | 1.34B | 1.8063 |
Vivos Therapeutics Inc (VVOS) 最新ニュース
Earnings call transcript: vivos beats Q4 2025 earnings expectations - Investing.com
Vivos Therapeutics Reports Full Year 2025 Financial Results - marketscreener.com
Vivos grows on sleep apnea services, but operating loss hits $19.9M - Stock Titan
Vivos Therapeutics Schedules Release of Full Year 2025 Financial Results - National Today
Vivos Therapeutics, Inc. to Release Full Year 2025 Financial Results and Conduct Conference Call on April 15, 2026 - Quiver Quantitative
Vivos Therapeutics Schedules Release of Full Year 2025 Financial Results and Conference Call - marketscreener.com
Vivos investors get 2025 results and strategy update at 5 p.m. ET - Stock Titan
Broadcom, Vivos Therapeutics and 3 stocks to watch heading into Monday - MSN
New to The Street to Broadcast on Fox Business on Monday, April 13, Featuring Virtuix Holdings (NASDAQ:VTIX), Medicus Pharma (NASDAQ:MDCX), YY Group Holdings (NASDAQ:YYGH), Vivos Therapeutics (NASDAQ:VVOS), and Stardust Power (NASDAQ - ACCESS Newswire
New to The Street Broadcasts on Bloomberg Television at 6:30 PM EST Featuring IGC Pharma (IGC), Vivos Therapeutics (VVOS), Acurx Pharmaceuticals (ACXP), and Equinox Gold (EQX) - Hilton Head Island Packet
Vivos Therapeutics (VVOS) 10% holder reports large stock and warrant stakes - Stock Titan
VVOS Stock Chart | VIVOS THERAPEUTICS INC (NASDAQ:VVOS) - ChartMill
Resistance Check: Can Vivos Therapeutics Inc maintain its current growth rate2026 Update & Safe Investment Capital Preservation Plans - baoquankhu1.vn
VVOS|Vivos Therapeutics Inc|Price:1.190|Chg%:-0.05 - TradingKey
VVOS Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Vivos Therapeutics closes $2.25M private placement with Seneca By Investing.com - Investing.com Canada
Vivos Therapeutics closes $2.25M private placement with Seneca - Investing.com
Vivos Therapeutics Completes Private Placement with Existing Private Equity Investor, New Seneca Partners - marketscreener.com
Portfolio Update: How does Vivos Therapeutics Inc score in quality rankingsTrade Exit Report & Accurate Technical Buy Alerts - baoquankhu1.vn
Broadcom, Vivos Therapeutics And 3 Stocks To Watch Heading Into Monday - Sahm
Vivos Therapeutics Enters Securities Purchase Agreement with V-CO Investors 3 LLC and Issues New Warrants – Form 8-K Filing Details - Minichart
VVOS Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
VVOS Technical Analysis & Stock Price Forecast - Intellectia AI
If You Invested $1,000 in Vivos Therapeutics Inc (VVOS) - Stock Titan
Vivos Therapeutics Completes Private Placement to Bolster Liquidity - TipRanks
Vivos Therapeutics Secures $0.85M PIPE, Converts $1.4M Bridge Note With Seneca Affiliate - TradingView — Track All Markets
Vivos Therapeutics (NASDAQ: VVOS) gets $850,000 PIPE cash plus $1,400,000 bridge note conversion - Stock Titan
Why did Vivos Therapeutics (VVOS) stock jump over 21% after hours - MSN
Form 8-KCurrent report - ADVFN
Vivos Therapeutics investor V-Co investors 3 LLC buys shares worth $1.8m By Investing.com - Investing.com
Why Did Vivos Therapeutics (VVOS) Stock Jump Over 21% After Hours - Benzinga
VVOS | Vivos Therapeutics, Inc. Common Insider Trading - Quiver Quantitative
Vivos Therapeutics (NASDAQ: VVOS) investor buys stock, pre-funded warrants - Stock Titan
Michael C. Skaff Discloses Investment at Vivos Therapeutics with 19.9% Stake - TradingView — Track All Markets
Investor group (NASDAQ: VVOS) funds Vivos with $2.39M PIPE and warrants - Stock Titan
Vivos Therapeutics Delays Annual Filing Amid Expansion - TipRanks
Vivos Therapeutics’ Supported Practices Achieve In-Network Status in Nevada - Sleep Review
Vivos Therapeutics (NASDAQ: VVOS) delays 2025 Form 10-K, cites SCN acquisition - Stock Titan
Buyback Watch: What are Vivos Therapeutics Incs earnings expectations2026 Recap & Advanced Swing Trade Entry Alerts - baoquankhu1.vn
Vivos Therapeutics, Inc. announced that it has received $2.389957 million in funding from V-Co Investors 3 LLC - marketscreener.com
Vivos Therapeutics Inc expected to post a loss of 48 cents a shareEarnings Preview - TradingView
Earnings Risk: Can Vivos Therapeutics Inc withstand a market correction2026 Drop Watch & Breakout Confirmation Alerts - baoquankhu1.vn
Vivos Therapeutics Inc (referred to as Vivos Therapeutics) recently disclosed a comprehensive cost optimization strategy. - Bitget
Vivos Therapeutics gains Nevada insurance network access By Investing.com - Investing.com Canada
Vivos Therapeutics gains Nevada insurance network access - Investing.com
Vivos Therapeutics Reports that Supported Professional Practices Have Achieved 'In-Network' Status Across Multiple Commercial Health Insurers and Medicare in Key Nevada Market - The Manila Times
Vivos Therapeutics Announces In-Network Insurance Coverage for OSA Treatments in Nevada and Initiates Cost Reduction Measures - Quiver Quantitative
More Las Vegas sleep apnea patients gain coverage as Vivos cuts costs - Stock Titan
Vivos Therapeutics Inc (VVOS) 財務データ
収益
当期純利益
現金流量
EPS
2.40%
0.00%
大文字化:
|
ボリューム (24 時間):